Future of Myelofibrosis Treatment is Moving Beyond Just JAK Inhibition

Related content

• Research Output

• Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis

  Research output: Contribution to journal › Article › peer-review